3M to invest nearly $150 million to advance capabilities in biopharma filtration technology
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jun 23
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing…
05 Apr 23
Certest Biotec, a biotech company based in San Mateo de Gállego, is committed to R&D as a driving force for
15 Mar 23
Through our deep technical knowledge and long-standing experience in the agri/food industry, Sonata is well-positioned to help customers…
13 Jan 23
The new model is intended for the design of new therapeutic targets for untreatable diseases and is expected…
05 Jan 23
The acquisition is expected to support Moderna’s suite of platform technologies, and OriCiro’s synthetic biology and enzyme technologies…
26 Oct 22
Taysha Gene Therapies is engaged in developing gene therapies for the treatment of Rett syndrome and giant axonal…
04 Oct 22
Viral vectors are said to be very important components required for manufacturing Kite’s cell therapies for the treatment…
14 Sep 22
"The solution we demonstrate is not hypothetical, the solution has been proven all over the world, and it…
09 Sep 22
The company, which is the life science business of Merck, will use the investment to further ramp up…
07 Sep 22
Emergence Therapeutics has secured license to use the GlycoConnect, HydraSpace and exatecan-based SYNtecan E linker-payload technologies to develop…